Karista’s Post

📣 Reality Check: DTX Investment Landscape, Still Hot or Cooling Down? Join our panel of #HealthtechLeaders as they discuss: ·  How do investors assess the current investment landscape for DTx startups, and what key factors influence investment decisions in this competitive environment ·  What specific strategies and criteria do investors look for in DTx startups to determine their readiness for investment rounds ·  With a sea of startups vying for attention, how can a company distinguish its pitch   🎙 Hear from: ·  Andy Molnar, CEO, Digital Therapeutics Alliance ·  Dominick Kennerson, SVP, HealthTech, HSBC Innovation Banking ·  Shamik J Parekh, Investor, Octopus Ventures ·  Ingrid Teigland Akay, Managing Partner, Hadean Ventures ·  Erki Mölder, Managing Partner, Verge HealthTech Fund ·  Josep Ll. Sanfeliu, Managing Partner, Asabys Partners Find out more: https://lnkd.in/eaQvGRNm #LSXWorld 

Effective collaboration between financial investors and strategics plays an important role in the fundraising ecosystem. How do investors and strategics approach these partnerships to achieve the best outcomes? In our upcoming #LSIEurope24 panel, "How do Financial Investors and Strategics Partner to Support Venture-Backed Startups?", we’ll hear from both financial investors and strategics as they explore the dynamics of these collaborations. Our panelists will share their stories and expertise on forming successful partnerships, navigating challenges, aligning goals, and driving innovation. Featured Panelists: • Nate Harrington (Moderator), Managing Partner, Philips Ventures • Carissa Bellardine Black, Senior Director, Venture Capital, Medtronic • Auriel August, MD, Principal, SANTÉ Ventures • Janke Dittmer, General Partner, Head of European HealthTech Investments, Gilde Healthcare • Alexander Schmitz, Partner, Endeavour Vision Join us at LSI Europe ‘24 this September 16-20th to see more panel sessions like this and connect with nearly 1,000 global Medtech and Healthtech leaders in Sintra, Portugal.

🌟 GoWest - Nordic Venture Capital Forum 2025 is officially in the books! 🌟 Key takeaways from the event: 🔹 Collaboration is key – Strong networks and partnerships drive innovation and growth. 🔹 Smart capital is crucial – Investors must offer more than money—expertise, strategy, and connections matter. 🔹 Embrace emerging technologies – AI, quantum computing, and deep tech are solving major global challenges. 🔹 Balance innovation with ethics – Responsible tech use and evolving regulations ensure trust and progress. 🔹 Effective communication matters – Strategic networking and storytelling can amplify impact and growth. 🙏 Thank you to everyone who stopped by our booth and downloaded our summaries! 📊 📲 Find all session summaries here: https://lnkd.in/dXtNJpCH Quotes in event summary from: Rune Bengtsson, Ingrid Teigland Akay, MD MBA, Juha Lehtola Thanks to organizers! Sofia Hjelmberg, Klementina Österberg, Alexandra Björk #GoWest2025 #Startups #Investors #Voxo GU Ventures, Västra Götalandsregionen, European Union

[MEET THE JURY 3] Get ready to meet the exceptional members of our jury! We are delighted to introduce 5 of the investors who will be evaluating the presentations of 20 EIC Fund companies on 13 November at the 𝗘𝗜𝗖 𝗮𝗻𝗱 𝗝&𝗝 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗮𝘆, 𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗯𝘆 EuroQuity - Bpifrance. ⭐ Lisanne Blauw Associate at Thuja Capital. Thuja manages several venture capital funds aimed at building and scaling companies in the fields of (bio)pharmaceuticals and medtech. In addition to generating a financial return for investors, Thuja’s investments positively impact the health and well-being of patients. Thuja serves physicians and patients worldwide by providing capital to daring entrepreneurs with ground-breaking product concepts locally.   ⭐ Claire Poulard Investment Director at Turenne Groupe. With more than € 350M dedicated to healthcare, Turenne Capital Healthcare team invests across the whole value chain of healthcare companies in Europe : from venture capital to buy out.   ⭐ Erki Mölder Managing Partner at Verge HealthTech Fund. Verge is an early-stage venture capital firm based in Singapore, exclusively focused on impactful healthcare technologies that have global applicability, especially for underserved populations. The team is composed of former founders or operators who take a hands-on, activist mindset to working with healthtech startups. The partners have invested in over 50 healthtech startups around the world since 2013.   ⭐ Fabienne Roussel, Partner at Vesalius Biocapital IV Partners, which is investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe. The companies in their portfolio are dedicated to addressing unmet medical and market needs while prioritizing strong intellectual property protection. Would you like to be part of this ? Make sure to secure your seat. #HealthTech #biotech #medtech #eicAccelerator #EUeic #Healthcare #Investors

At MedTech World 2024, we caught up with Miguel Bourge from Malta Venture Capital - MVC, who shared insights about their €10M fund dedicated to boosting innovative startups in sectors like #agritech, #AI, and #MedTech. 💡 Exciting news: they’re gearing up to make their first-ever MedTech investment soon! Miguel emphasized the fund's mission to bridge the financing gap for startups in Malta, fostering commercialization and growth. 🙌 Don’t miss the chance to watch more interviews on our YouTube Channel where industry leaders like Miguel shed light on MedTech and the innovations transforming the future! YouTube Channel Link: https://lnkd.in/dm5Aqwbm #MedTechmalta #MedTechindustry #healthcare #AI MedTechMalt2025

Interesting and exciting launch in the Swiss VC space 👉 Deep Tech Nation Switzerland #Switzerland should be perceived internationally as a leading deep tech nation. To achieve this, Deep Tech Nation Switzerland Foundation aims to mobilise CHF 50 billion in venture capital for Swiss start-ups and scale-ups, indirectly creating up to 100,000 new jobs. Launched at the Swiss Economic Forum, supported by Swisscom UBS Vaudoise Assurances SIX ROLEX Stadler Swiss Re SICPA NZZ and University of Zurich More info here: deeptechnation.ch #venturecapital #startup #deeptech #foodtech #biotech #agritech #fintech #investing

🚀 A Conversation on Enabling Healthcare Innovation with Venture Capital: I recently had the privilege to welcome Nicole Graner from the Süddeutsche Zeitung at our YZR Capital headquarters. Article in 1st comment. Tldr: 🔎 Critical need for venture capital in fostering healthcare innovation. 🔎 How our expertise-driven approach is making a difference. 🔎 My journey as a physician, entrepreneur and investor, always deeply intertwined with my passion for #healthtech. 💡 That's why: alongside Markus Feuerecker I co-founded YZR Capital with a clear vision: to propel European healthtech startups into global leadership positions. 💡 We strongly believe that our team’s expertise in health is key to supporting founders who are dedicated to change the European healthtech ecosystem. ✔ Apparently our name is difficult to pronounce – for everyone who is still wondering, it’s “wise” with an R at the end ;) -> Thanks again to Nicole - it was a pleasure! And thanks to the fantastic team at YZR Capital - Christina Schmidt, Paul Epple, Urs Keller, Holger Ebersberger, Elmar Willebrand, Michael Dr. Bitzer. #HealthTech #VentureCapital #Innovation

Download: 'Venture Pulse Q4 2024 - Global Analysis of Venture Funding' from KPMG "VC investors in Japan have shown interest in a diversity of sectors. The healthtech — particularly digital healthcare services — semiconductor, and aerospace and defence sectors have also gained a lot of traction among VC investors in Japan. Deeptech has also grown on the radar of VC investors, in part because of government efforts to encourage investment in the space. The government has been very active in supporting startups in Japan; it is currently in the latter half of its Startup Development Five Year Plan." https://lnkd.in/eaj7F_DC #venturecapital #vcnews #kpmg #venturepulse #technologynews #AI #semiconductors #healthtech 

🚀 Hear for the CO-AX Community 🚀 "CO-AX has helped us open several doors, everything from quality assurance of the business to capital raising/financing and exposure to relevant partners and customers. Their support has been fantastic, with a clear tailored focus on what has been important for our particular business." Says Peder Remman, CEO Boneprox Our portfolio companies showcases AI-driven, deep tech, and innovative startups that are transforming the way healthcare is delivered. These companies, from pre-seed to growth stages, are addressing global health challenges with cutting-edge solutions. Learn more about the CO-AX companies: https://lnkd.in/dCEaeHiH Learn more about us: https://lnkd.in/e6MGJd_u Join us in our vision of accelerating tech for health. Apply to the program now! https://lnkd.in/e-JujBy6 #COAX #startup #accelerate #healthtech #portfolio